Cargando…
Atorvastatin May Attenuate Recurrence of Chronic Subdural Hematoma
Objective: Chronic subdural hematoma (CSDH) is a common form of intracranial hemorrhage with a substantial recurrence rate. Atorvastatin may reduce CSDH via its anti-inflammatory and pro-angiogenesis effects, but its effectiveness for preventing recurrent CSDH has never been explored. We hypothesize...
Autores principales: | Liu, Hua, Luo, Zhengxiang, Liu, Zhongkun, Yang, Jian, Kan, Shifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923224/ https://www.ncbi.nlm.nih.gov/pubmed/27445673 http://dx.doi.org/10.3389/fnins.2016.00303 |
Ejemplares similares
-
Retraction: Atorvastatin May Attenuate Recurrence of Chronic Subdural Hematoma
Publicado: (2016) -
Efficacy of atorvastatin administration after surgery in patients with chronic subdural hematoma
por: Xu, Wuhuan, et al.
Publicado: (2023) -
Effects of atorvastatin on chronic subdural hematoma: A systematic review
por: Qiu, Sheng, et al.
Publicado: (2017) -
Atorvastatin combined with dexamethasone promote hematoma absorption in an optimized rat model of chronic subdural hematoma
por: Wang, Dong, et al.
Publicado: (2021) -
Effects of atorvastatin on chronic subdural hematoma: A systematic review: Erratum
Publicado: (2017)